View Cart (0 items)

Pharmaceutical

UK pharma industry welcomes government investment in science

The pharmaceutical industry in the United Kingdom has welcomed the government's Science and Innovation strategy, which was announced last week.
Read More

Japan's Otsuka to acquire Avanir Pharmaceuticals for $3.5 billion

The Japanese company said on Tuesday that this acquisition would strengthen its business in the area of neurological conditions.
Read More

New Eastman copolyester for medical products could allow faster processing

A styrene-free alternative to high-impact polystyrene (HIPS) for opaque medical packaging has been introduced by Eastman Chemical Company in the European market.
Read More

Roche to make diagnostic products in China

Roche is to establish a new diagnostic manufacturing facility in China, investing 450 million Swiss francs ($463 million) over the next three years.
Read More

Three Nigerian pharmaceutical firms get WHO certification

Three pharmaceutical manufacturers in Nigeria have been certified by the World Health Organization (WHO) to produce drugs in accordance with its Good Manufacturing Practice (GMP).
Read More

Consort agrees to $372 million acquisition of Aesica

U.K.-based healthcare company Consort Medical plc announced on Tuesday an agreement to acquire Aesica Pharmaceuticals.
Read More

PCI acquires clinical trail services company Biotec

Pharmaceutical packaging services provider PCI has expanded its presence in the European Union with the acquisition of Biotec Services International.
Read More

New heart failure drug could cut deaths by 20%

Swiss pharmaceuticals group Novartis is planning to launch a new drug that has the potential to cut cardiovascular death and admissions to hospital by 20%.
Read More

Global pharmaceutical sales projected to reach $1 trillion in 2014

The outlook for the pharmaceutical industry is bright, according to a new report that identifies a number of positive trends.
Read More

FDA's regulatory policy not biased against Indian drug makers

Amid news of regulatory action taken by the U.S. watchdog against pharmaceutical companies, at first glance it would appear that mostly Indian companies have come under fire.
Read More